Page last updated: 2024-10-26

ethoxzolamide and Breast Cancer

ethoxzolamide has been researched along with Breast Cancer in 2 studies

Ethoxzolamide: A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.
ethoxzolamide : A sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Morsy, SM1
Badawi, AM1
Cecchi, A1
Scozzafava, A1
Supuran, CT1
Mboge, MY1
Combs, J1
Singh, S1
Andring, J1
Wolff, A1
Tu, C1
Zhang, Z1
McKenna, R1
Frost, SC1

Other Studies

2 other studies available for ethoxzolamide and Breast Cancer

ArticleYear
Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines.
    Journal of enzyme inhibition and medicinal chemistry, 2009, Volume: 24, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Colonic

2009
Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer.
    Journal of medicinal chemistry, 2021, 02-11, Volume: 64, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbo

2021